• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次实验室检测值对 ICU 住院 COVID-19 患者预后的影响。

Effect of first application laboratory values on the prognosis of COVID-19 patients hospitalized in the intensive care unit.

机构信息

Department of Chest Diseases, Adıyaman University, Department of Internal Medicine, Medicine Faculty, Adıyaman, Turkey.

出版信息

Eur Rev Med Pharmacol Sci. 2022 May;26(9):3361-3366. doi: 10.26355/eurrev_202205_28756.

DOI:10.26355/eurrev_202205_28756
PMID:35587089
Abstract

OBJECTIVE

The aim of the study was to investigate the effect of blood values at first admission to the hospital on predicting mortality in COVID-19 patients hospitalized in the intensive care unit (ICU).

PATIENTS AND METHODS

The blood parameters of 284 intensive care patients, who were diagnosed with COVID-19 via the Real-Time Polymerase Chain Reaction (RT-PCR) for SARS-CoV-2 RNA test, at first admission to the hospital, were evaluated. The contribution of these parameters to predicting mortality was analyzed.

RESULTS

No significant relationship was found between complete blood count and mortality. However, it was determined that the ferritin, ALT, D-dimer, and urea levels significantly affected the mortality rates in intensive care patients.

CONCLUSIONS

The ferritin, ALT, D-dimer, and urea levels of patients who were admitted to the ICU due to COVID-19, at first admission to the hospital, were significant in predicting mortality. Therefore, it is recommended that these parameters will be evaluated at the first application.

摘要

目的

本研究旨在探讨患者首次入院时的血液值对预测因 COVID-19 入住重症监护病房(ICU)的患者死亡率的影响。

患者和方法

评估了 284 名经 SARS-CoV-2 RNA 检测的实时聚合酶链反应(RT-PCR)确诊为 COVID-19 的重症监护患者首次入院时的血液参数。分析了这些参数对预测死亡率的贡献。

结果

全血细胞计数与死亡率之间无显著关系。然而,铁蛋白、ALT、D-二聚体和尿素水平显著影响了重症监护患者的死亡率。

结论

因 COVID-19 入住 ICU 的患者首次入院时的铁蛋白、ALT、D-二聚体和尿素水平对死亡率有显著预测作用。因此,建议在首次就诊时评估这些参数。

相似文献

1
Effect of first application laboratory values on the prognosis of COVID-19 patients hospitalized in the intensive care unit.首次实验室检测值对 ICU 住院 COVID-19 患者预后的影响。
Eur Rev Med Pharmacol Sci. 2022 May;26(9):3361-3366. doi: 10.26355/eurrev_202205_28756.
2
Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients.某些生化和血液学参数在预测 COVID-19 患者死亡率和 ICU 入院率中的作用。
Rev Assoc Med Bras (1992). 2021 Jul 9;67Suppl 1(Suppl 1):67-73. doi: 10.1590/1806-9282.67.Suppl1.20200788. eCollection 2021.
3
Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.回顾性队列观察研究比较了分枝杆菌 w 联合标准治疗与单纯标准治疗对危重症 COVID-19 患者的疗效。
J Assoc Physicians India. 2022 Jul;70(7):11-12. doi: 10.5005/japi-11001-0044.
4
Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.入院时铁蛋白水平升高可预测 COVID-19 患者的重症监护病房死亡率。
Med Clin (Barc). 2021 Apr 9;156(7):324-331. doi: 10.1016/j.medcli.2020.11.030. Epub 2020 Dec 25.
5
Presepsin as a Novel Biomarker in predicting In-hospital Mortality in Patients With COVID-19 Pneumonia.可溶性 CD14 亚型(Presepsin)作为一种新型生物标志物预测 COVID-19 肺炎患者住院死亡率。
Int J Infect Dis. 2022 May;118:155-163. doi: 10.1016/j.ijid.2022.02.054. Epub 2022 Mar 3.
6
Association between ABO blood types and the prognosis and mortality rates in patients with severe COVID-19 admitted in the intensive care unit of a tertiary-level hospital in Turkey.在土耳其一家三级医院的重症监护病房中,ABO 血型与重症 COVID-19 患者的预后和死亡率之间的关系。
Curr Med Res Opin. 2022 Sep;38(9):1515-1520. doi: 10.1080/03007995.2022.2101806. Epub 2022 Jul 29.
7
Routine laboratory parameters in estimating mortality and morbidity in COVID-19 diagnosed cases followed in the intensive care unit.在重症监护病房中对 COVID-19 确诊病例进行死亡率和发病率评估时的常规实验室参数。
Eur Rev Med Pharmacol Sci. 2023 Jun;27(12):5885-5892. doi: 10.26355/eurrev_202306_32828.
8
Independent predictors of in-hospital mortality and the need for intensive care in hospitalized non-critical COVID-19 patients: a prospective cohort study.住院非危重新冠肺炎患者院内死亡率和重症监护需求的独立预测因素:一项前瞻性队列研究。
Intern Emerg Med. 2022 Aug;17(5):1413-1424. doi: 10.1007/s11739-022-02962-6. Epub 2022 May 20.
9
Evaluation of simple laboratory parameters in SARS-CoV-2 infection: the role of ratios.评估 SARS-CoV-2 感染中的简单实验室参数:比值的作用。
Infect Dis (Lond). 2022 Dec;54(12):924-933. doi: 10.1080/23744235.2022.2131902. Epub 2022 Oct 12.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.